Biotech Stocks

Related articles

MGC Pharmaceuticals Shares Lift on Landmark UK Import Permit (ASX:MXC)

MGC Pharmaceuticals said this marks the first time an epilepsy treatment containing THC and still undergoing clinical trials was approved by UK authorities for import.   The news saw MGC Pharmaceuticals [ASX:MXC] shares jump 10% at the time of writing.  

Hazer Share Price Sinks on $7 Million Capital Raise Update (ASX:HZR)

The Hazer Group [ASX:HZR] share price sinks as the hydrogen tech developer completes a $7 million placement. Hazer will also invite eligible shareholders to participate in a share purchase plan to raise up to $7 million.

Rhinomed Share Price Surges 20% on Government Deal (ASX:RNO)

The Rhinomed [ASX:RNO] share price is soaring this morning after the Victorian Department of Health placed initial orders for one million Rhinoswabs for SARS-CoV-2 testing.

Imugene Share Price Sink 7% after Flagging Three New Trials (ASX:IMU)

The Imugene [ASX:IMU] share price is floundering today on the back of an announcement regarding its HER-Vaxx immunotherapy in HER-2 positive gastric cancer trial.

7% Up For Immutep Share Price — Progresses Clinical Trials (ASX:IMM)

Small-cap biotech stock Immutep Ltd [ASX:IMM] is on the up today. The IMM share price is currently trading 7.92% higher at time of writing...

Mesoblast Shares Tumble as Losses Widen (ASX:MSB)

The MSB share price down 14%. The Mesoblast [ASX:MSB] posted a FY21 net loss of $98.8 million as the FDA asks for further trials of MSB’s emergency COVID treatment...